Cargando…
Large increase in bloodstream infections with carbapenem-resistant Acinetobacter species during the first 2 years of the COVID-19 pandemic, EU/EEA, 2020 and 2021
Recent data from the European Antimicrobial Resistance Surveillance Network (EARS-Net) show a large increase of +57% in Acinetobacter species bloodstream infections in the European Union and European Economic Area in the first years of the COVID-19 pandemic (2020–2021) compared with 2018–2019. Most...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673235/ https://www.ncbi.nlm.nih.gov/pubmed/36398574 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.46.2200845 |
| _version_ | 1784832907818303488 |
|---|---|
| author | Kinross, Pete Gagliotti, Carlo Merk, Hanna Plachouras, Diamantis Monnet, Dominique L Högberg, Liselotte Diaz Strauss, Reinhild Mertens, Karl Sabtcheva, Stefana Andrasevic, Arjana Tambic Maikanti, Panagiota Žemličková, Helena Hasman, Henrik Ivanova, Marina Räisänen, Kati Maugat, Sylvie Noll, Ines Mellou, Kassiani Tóth, Ákos Helgason, Kristján Orri Murchan, Stephen Errico, Giulia Voita, Ieva Walser-Domjan, Esther Miciulevičienė, Jolanta Perrin, Monique Scicluna, Elizabeth Anne Woudt, Sjoukje HS Samuelsen, Ørjan Żabicka, Dorota Caniça, Manuela Popescu, Gabriel Adrian Schréterová, Eva Ribič, Helena Aracil García, Maria Belén Billström, Hanna |
| author_facet | Kinross, Pete Gagliotti, Carlo Merk, Hanna Plachouras, Diamantis Monnet, Dominique L Högberg, Liselotte Diaz Strauss, Reinhild Mertens, Karl Sabtcheva, Stefana Andrasevic, Arjana Tambic Maikanti, Panagiota Žemličková, Helena Hasman, Henrik Ivanova, Marina Räisänen, Kati Maugat, Sylvie Noll, Ines Mellou, Kassiani Tóth, Ákos Helgason, Kristján Orri Murchan, Stephen Errico, Giulia Voita, Ieva Walser-Domjan, Esther Miciulevičienė, Jolanta Perrin, Monique Scicluna, Elizabeth Anne Woudt, Sjoukje HS Samuelsen, Ørjan Żabicka, Dorota Caniça, Manuela Popescu, Gabriel Adrian Schréterová, Eva Ribič, Helena Aracil García, Maria Belén Billström, Hanna |
| author_sort | Kinross, Pete |
| collection | PubMed |
| description | Recent data from the European Antimicrobial Resistance Surveillance Network (EARS-Net) show a large increase of +57% in Acinetobacter species bloodstream infections in the European Union and European Economic Area in the first years of the COVID-19 pandemic (2020–2021) compared with 2018–2019. Most were resistant to carbapenems, from intensive care units, and in countries with ≥ 50% carbapenem resistance in Acinetobacter spp. in 2018–2019. This highlights the requirement for reinforced Acinetobacter preparedness and infection prevention and control in Europe. |
| format | Online Article Text |
| id | pubmed-9673235 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Centre for Disease Prevention and Control (ECDC) |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96732352022-11-29 Large increase in bloodstream infections with carbapenem-resistant Acinetobacter species during the first 2 years of the COVID-19 pandemic, EU/EEA, 2020 and 2021 Kinross, Pete Gagliotti, Carlo Merk, Hanna Plachouras, Diamantis Monnet, Dominique L Högberg, Liselotte Diaz Strauss, Reinhild Mertens, Karl Sabtcheva, Stefana Andrasevic, Arjana Tambic Maikanti, Panagiota Žemličková, Helena Hasman, Henrik Ivanova, Marina Räisänen, Kati Maugat, Sylvie Noll, Ines Mellou, Kassiani Tóth, Ákos Helgason, Kristján Orri Murchan, Stephen Errico, Giulia Voita, Ieva Walser-Domjan, Esther Miciulevičienė, Jolanta Perrin, Monique Scicluna, Elizabeth Anne Woudt, Sjoukje HS Samuelsen, Ørjan Żabicka, Dorota Caniça, Manuela Popescu, Gabriel Adrian Schréterová, Eva Ribič, Helena Aracil García, Maria Belén Billström, Hanna Euro Surveill Rapid Communication Recent data from the European Antimicrobial Resistance Surveillance Network (EARS-Net) show a large increase of +57% in Acinetobacter species bloodstream infections in the European Union and European Economic Area in the first years of the COVID-19 pandemic (2020–2021) compared with 2018–2019. Most were resistant to carbapenems, from intensive care units, and in countries with ≥ 50% carbapenem resistance in Acinetobacter spp. in 2018–2019. This highlights the requirement for reinforced Acinetobacter preparedness and infection prevention and control in Europe. European Centre for Disease Prevention and Control (ECDC) 2022-11-17 /pmc/articles/PMC9673235/ /pubmed/36398574 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.46.2200845 Text en This article is copyright of the authors or their affiliated institutions, 2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
| spellingShingle | Rapid Communication Kinross, Pete Gagliotti, Carlo Merk, Hanna Plachouras, Diamantis Monnet, Dominique L Högberg, Liselotte Diaz Strauss, Reinhild Mertens, Karl Sabtcheva, Stefana Andrasevic, Arjana Tambic Maikanti, Panagiota Žemličková, Helena Hasman, Henrik Ivanova, Marina Räisänen, Kati Maugat, Sylvie Noll, Ines Mellou, Kassiani Tóth, Ákos Helgason, Kristján Orri Murchan, Stephen Errico, Giulia Voita, Ieva Walser-Domjan, Esther Miciulevičienė, Jolanta Perrin, Monique Scicluna, Elizabeth Anne Woudt, Sjoukje HS Samuelsen, Ørjan Żabicka, Dorota Caniça, Manuela Popescu, Gabriel Adrian Schréterová, Eva Ribič, Helena Aracil García, Maria Belén Billström, Hanna Large increase in bloodstream infections with carbapenem-resistant Acinetobacter species during the first 2 years of the COVID-19 pandemic, EU/EEA, 2020 and 2021 |
| title | Large increase in bloodstream infections with carbapenem-resistant Acinetobacter species during the first 2 years of the COVID-19 pandemic, EU/EEA, 2020 and 2021 |
| title_full | Large increase in bloodstream infections with carbapenem-resistant Acinetobacter species during the first 2 years of the COVID-19 pandemic, EU/EEA, 2020 and 2021 |
| title_fullStr | Large increase in bloodstream infections with carbapenem-resistant Acinetobacter species during the first 2 years of the COVID-19 pandemic, EU/EEA, 2020 and 2021 |
| title_full_unstemmed | Large increase in bloodstream infections with carbapenem-resistant Acinetobacter species during the first 2 years of the COVID-19 pandemic, EU/EEA, 2020 and 2021 |
| title_short | Large increase in bloodstream infections with carbapenem-resistant Acinetobacter species during the first 2 years of the COVID-19 pandemic, EU/EEA, 2020 and 2021 |
| title_sort | large increase in bloodstream infections with carbapenem-resistant acinetobacter species during the first 2 years of the covid-19 pandemic, eu/eea, 2020 and 2021 |
| topic | Rapid Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673235/ https://www.ncbi.nlm.nih.gov/pubmed/36398574 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.46.2200845 |
| work_keys_str_mv | AT kinrosspete largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT gagliotticarlo largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT merkhanna largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT plachourasdiamantis largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT monnetdominiquel largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT hogbergliselottediaz largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT straussreinhild largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT mertenskarl largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT sabtchevastefana largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT andrasevicarjanatambic largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT maikantipanagiota largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT zemlickovahelena largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT hasmanhenrik largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT ivanovamarina largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT raisanenkati largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT maugatsylvie largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT nollines largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT melloukassiani largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT tothakos largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT helgasonkristjanorri largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT murchanstephen largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT erricogiulia largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT voitaieva largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT walserdomjanesther largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT miciulevicienejolanta largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT perrinmonique largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT sciclunaelizabethanne largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT woudtsjoukjehs largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT samuelsenørjan largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT zabickadorota largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT canicamanuela largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT popescugabrieladrian largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT schreterovaeva largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT ribichelena largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT aracilgarciamariabelen largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 AT billstromhanna largeincreaseinbloodstreaminfectionswithcarbapenemresistantacinetobacterspeciesduringthefirst2yearsofthecovid19pandemiceueea2020and2021 |